Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 10,716 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 10,716 shares of Phreesia stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $294,475.68. Following the sale, the chief operating officer now owns 764,307 shares in the company, valued at approximately $21,003,156.36. This trade represents a 1.38 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Trading Down 1.7 %

NYSE PHR traded down $0.49 during trading on Wednesday, reaching $28.81. 384,950 shares of the stock traded hands, compared to its average volume of 392,842. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.90. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of -19.60 and a beta of 0.94. The stock’s 50-day moving average price is $24.57 and its 200 day moving average price is $23.20.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.58) EPS. Analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Analyst Ratings Changes

PHR has been the topic of a number of recent analyst reports. KeyCorp boosted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and upped their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Robert W. Baird lowered their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Truist Financial upped their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, Piper Sandler reissued an “overweight” rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a report on Wednesday. Thirteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $31.15.

Institutional Investors Weigh In On Phreesia

Several large investors have recently modified their holdings of PHR. R Squared Ltd bought a new position in shares of Phreesia during the 4th quarter valued at about $30,000. International Assets Investment Management LLC raised its holdings in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the period. XTX Topco Ltd bought a new position in Phreesia in the third quarter valued at approximately $247,000. Hsbc Holdings PLC bought a new stake in shares of Phreesia during the second quarter worth $301,000. Finally, Intech Investment Management LLC acquired a new stake in shares of Phreesia during the third quarter worth $316,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.